Istituto Oncologico Veneto IOV - IRCCS, Via Gattamelata, 64, 35128, Padova, Italy.
"La Sapienza" University, Rome, Italy.
BMC Palliat Care. 2019 Apr 5;18(1):34. doi: 10.1186/s12904-019-0420-y.
Newer models of palliative and supportive cancer care view the person as an active agent in managing physical and psychosocial challenges. Therefore, personal efficacy is an integral part of this model. Due to the lack of instruments in Italian to assess coping self-efficacy, the present study included the translation and validation of the Italian version of the Cancer Behavior Inventory-Brief (CBI-B/I) and an initial analysis of the utility of self-efficacy for coping in an Italian sample of palliative care patients.
216 advanced cancer patients who attended palliative care clinics were enrolled. The CBI-B/I was administered along with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), the Mini Mental Adjustment to Cancer Scale (Mini-MAC), the Cancer Concerns Checklist (CCL), and the Hospital Anxiety and Depression Scale (HADS). The Eastern Cooperative Oncology Group Performance Status (ECOG-PS) ratings of functional capacity were completed by physicians.
Factor analysis confirmed that the structure of the CBI-B/I was consistent with the English version. Internal consistency reliability and significant correlations with the EORTC QLQ-C30, Mini-MAC, and HADS supported the concurrent validity of the CBI-B/I. Differences in CBI-B/I scores for high versus low levels of the CCL and ECOG-PS supported the clinical utility of the CBI-B/I.
The CBI-B/I has strong psychometric properties and represents an important addition to newer model of palliative and supportive care. In order to improve clinical practice, the CBI-B/I could be useful in identifying specific self-efficacy goals for coping in structured psychosocial interventions.
较新的姑息治疗和支持性癌症护理模式将患者视为管理身体和心理社会挑战的积极参与者。因此，个人效能是该模式的一个组成部分。由于缺乏评估应对自我效能的意大利语工具，本研究包括翻译和验证意大利语版癌症行为量表-简短版（CBI-B/I），并初步分析自我效能在意大利姑息治疗患者样本中的应对作用。
共纳入 216 名接受姑息治疗诊所治疗的晚期癌症患者。CBI-B/I 与欧洲癌症研究与治疗组织生活质量问卷核心 30 版（EORTC QLQ-C30）、简易心理调整癌症量表（Mini-MAC）、癌症关注清单（CCL）和医院焦虑抑郁量表（HADS）一起进行评估。医生完成东部肿瘤合作组体能状态（ECOG-PS）评分以评估功能能力。
因子分析证实 CBI-B/I 的结构与英文版一致。内部一致性信度和与 EORTC QLQ-C30、Mini-MAC 和 HADS 的显著相关性支持了 CBI-B/I 的同时效度。CBI-B/I 评分在 CCL 和 ECOG-PS 高低水平之间的差异支持了 CBI-B/I 的临床实用性。
CBI-B/I 具有较强的心理测量学特性，是姑息治疗和支持性护理新模式的重要补充。为了改善临床实践，CBI-B/I 可用于在结构化心理社会干预中确定应对的特定自我效能目标，从而对患者有所帮助。
